CPSCCPSC · Productos de consumo·N.º oficial 23146
Aprepitant capsules and Lidocaine and Prilocaine cream
Publicado el 9 de marzo de 2023 · Inicio del retiro: 9 de marzo de 2023
Qué peligro representa
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Qué hacer
Consumers should immediately secure the medications out of the sight and reach of children and contact Sandoz for a free child resistant pouch to store the products. Once the medication is secured, consumers can continue to use the medication as directed.
Detalles del retiro
- Marca
- Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream)
- Fabricante
- Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream)
- Distribuidor
- Pharmacies nationwide as a prescribed medicine from October 2020 through January 2023. The prices of the medications varied based on health insurance terms and other factors.
- País
- US
¿Vendes productos como este?
Recalert vigila todo tu catálogo contra retiros como este, automáticamente.